Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

AstraZeneca to develop mHealth cardiovascular services

Willwork with Vodafone in a new global partnership

Digital pharmaAstraZeneca has teamed up with telecoms giant Vodafone to develop a range of mHealth services for patients with cardiovascular conditions.

The global deal will see the partners create new mobile and internet-based services to support patients in areas such as medication adherence and self-management.

On the AZ side the project will be led by the pharma company's 'intelligent pharmaceutical group', which will work closely with local AZ marketing teams.  

Andy Jones, the company's VP pharmaceutical innovation, said: “It is really exciting to see the progress being made in this area. This work is an excellent example of collaboration between AstraZeneca and Vodafone.

"Together we believe we are delivering something that will bring real benefit to patients in this important therapeutic area.”

Vodafone will provide the technology, infrastructure and expertise for these services, as well as the ability to capture data from a variety of sources to improve overall engagement between patients and their health care professionals (HCPs).

Patients will also be offered educational material - personalised for their needs - and the overall service package will include coaching and treatment support elements.

Vodafone said it would be designing the services in such a way to ensure they work across geographies and can adapt to local variations in regulations and patient care.

The company has previously partnered with GlaxoSmithKline to improve childhood vaccination rates in Mozambique and its mHealth projects include collaborating on a Kenyan mHealth pilot scheme to improve maternal health information and education.

Vodafone's latest deal comes as Europe awaits publication of the European Commission's mHealth Green Paper, that will seek views on issues like data protection, privacy compliance, patient safety and legal clarity.

21st March 2014

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics